RGEN
NASDAQ
US
Repligen Corporation - Common Stock
$117.78
▼ $-0.54
(-0.46%)
Vol 797K
9
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$9.2B
P/E
5307.1
ROE
0.1%
Margin
0.3%
D/E
25.82
Beta
1.16
52W
$103–$183
Wall Street Consensus
28 analysts · Apr 20267
Strong Buy
16
Buy
5
Hold
0
Sell
0
Strong Sell
82.1%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.45 | $0.49 | +$0.04 |
| Sep 2025 | $0.43 | $0.46 | +$0.03 |
| Jun 2025 | $0.40 | $0.37 | $-0.03 |
| Mar 2025 | $0.35 | $0.39 | +$0.04 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -0.7% | -0.7% | -0.7% | -0.7% | 0.1% | 0.1% |
| P/E (TTM) | — | — | — | 4824.95 | 5351.02 | 5307.14 |
| Net Margin | 8.2% | -2.0% | -2.0% | 0.2% | 0.2% | 0.2% |
| Gross Margin | 51.0% | 51.0% | 51.0% | 51.6% | 51.6% | 51.6% |
| D/E Ratio | 25.89 | 25.89 | 25.89 | 25.89 | 25.82 | 25.82 |
| Current Ratio | 8.59 | 8.59 | 8.59 | 8.59 | 8.36 | 8.36 |
Key Ratios
ROA (TTM)
0.1%
P/S (TTM)
13.03
P/B
4.1
EPS (TTM)
$0.03
CF/Share
$3.18
Rev Growth 3Y
-1.8%
52W High
$182.52
52W Low
$102.97
$102.97
52-Week Range
$182.52
How does RGEN compare to Life Sciences Tools & Services peers?
Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies
RGEN valuation vs Life Sciences Tools & Services peers
P/E ratio
5307.1
▲
16220%
above
peers
(32.5)
vs Peers
vs Industry
Undervalued
P/S ratio
13.0
▲
241%
above
peers
(3.8)
vs Peers
vs Industry
Overvalued
P/B ratio
4.1
▲
10%
above
peers
(3.7)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
RGEN profitability vs Life Sciences Tools & Services peers
ROE
0.1%
▲
103%
above
peers
(-3.3%)
vs Peers
vs Industry
Top tier
Net margin
0.3%
▲
103%
above
peers
(-9.4%)
vs Peers
vs Industry
Top tier
Gross margin
51.6%
▲
7%
above
peers
(48.0%)
vs Peers
vs Industry
In line
ROA
0.1%
▲
102%
above
peers
(-2.6%)
vs Peers
vs Industry
Top tier
RGEN financial health vs Life Sciences Tools & Services peers
D/E ratio
25.8
▼
29%
below
peers
(36.5)
vs Peers
vs Industry
Above avg
Current ratio
8.4
▲
147%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.2
▼
19%
below
peers
(1.4)
vs Peers
vs Industry
More volatile
RGEN fundamentals radar
RGEN
Peer median
Industry
RGEN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
RGEN vs peers: key metrics
Latest News
Copper-Aluminum Divergence Unveils The Complex Iran War Impact
Yahoo Finance · Apr 05
Ex-NYC Mayor de Blasio Joins China-Linked Far-Left Group At Anti-U.S. "Emergency Meeting" …
ZeroHedge · Apr 05
Australia Considers Emergency Powers To Protect Domestic Gas Supply
ZeroHedge · Apr 03
Korean Air takes emergency action as fuel prices soar
BBC Business · Mar 31
US appeals court voids $16.1 billion judgment against Argentina over YPF seizure
Yahoo Finance · Mar 27